CIK 0001108205
- Non-accelerated filer
- Smaller reporting company
CURIS INC
Sign in to watch- Ticker
- CRIS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 043505116
- Phone
- +1 617-503-6500
- Business address
- 128 SPRING STREET, BUILDING C, SUITE 500, LEXINGTON, MA, 02421
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Director sold 29,705 shares at $4.50 ($133,673)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 6,800 shares at $3.68 ($25,024)
- 4 Open-market sale Director sold 25,000 shares at $3.25 ($81,250)
- 4 Open-market sale CEO and Director sold 125,000 shares at an average $3.25 ($406,788)
- 4 Open-market sale Director sold 11,987 shares at $3.27 ($39,197)
- 4 Open-market sale Director sold 50,000 shares at $3.28 ($164,000)
- 4 Exercise or conversion Director acquired 397,500 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 13 of 24 · 475 filings